GENE ONLINE|News &
Opinion
Blog

.

Зеркало официального сайта всегда доступно для входа на Мостбет, даже при ограничениях. Скачать Mostbet – это шаг к удобству и азартным развлечениям.

Если вы ищете место для увлекательных ставок, обратите внимание на Joycasino, где лучшие предложения для игроков ждут вас.
2022-06-08| M&A

EQT and Mubadala to Acquire Envirotainer in $3 Billion Deal

by Fujie Tham
Share To

Swedish EQT Private Equity and Abu Dhabi’s Mubadala Investment Company have agreed to make a majority investment in Envirotainer, the leading medical freight company specializing in cold containers for transporting temperature-sensitive pharmaceutical products.

The pair will be acquiring Envirotainer from Cinven and Novo Holdings, which purchased the business back in 2018 for about $1 billion. Envirotainer played a major role during the peak of the COVID-19 pandemic, the company’s containers had transported more than half (250 million doses) of global vaccines by air cargo as of early 2021.

Related article: RNA Therapeutics Beyond Vaccines

 

Envirotainer’s Mission-Critical Role in Healthcare Ecosystem

 

The Company developed and marketed the first shipping container with an active temperature control system in 1995, enabling it to meet the industry’s complex need for rapid and safe cold chain shipments of biopharmaceuticals at low and stable temperatures. Today, Envirotainer supports the transportation of approximately 2 million doses of medicines per day, ensuring medicines are safely delivered to destinations around the globe with its fleet of 6700 refrigerated containers.

“This long-term partnership will strengthen Envirotainer and help us deliver on our purpose of enabling access to life-saving pharmaceuticals. At the same time, this investment, from such esteemed investors, confirms the strength of Envirotainer’s business model and the company’s very exciting future,” Peter Gisel-Ekdahl, Envirotainer’s CEO said.

EQT and Mubadala will seek to support Envirotainer’s next phase of growth by accelerating expansion in the Asia Pacific region while leveraging EQT’s local-with-locals approach and Mubadala’s global network to do so. Both firms will help scale the newly launched CryoSure lineup and continue the successful roll-out of the third-generation Releye air cargo platform.

EQT manages assets of around €77 billion globally, and its focus ranges from real estate, technology, and healthcare. Recently, EQT has been restructuring its holdings in the healthcare and logistics sector. In 2021, EQT and Goldman Sachs acquired Parexel for $8.5 billion.

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
Teladoc Dials Up Virtual Care with $70 Million Acquisition of Catapult
2025-02-06
SEQENS: A Strategic Blueprint for Supply Chain Success in Pharmaceuticals
2025-01-29
Drug Promotion, Nonprescription Pathways, and Advanced Manufacturing: FDA’s Key Focus Areas in 2024 and What’s Next for 2025
2025-01-23
LATEST
Beyond Pouch Packaging: Hanmi Pharmaceutical Introduces a New Automated Vial Dispensing Solution in Canada and the United States
2025-02-13
NASA Says There’s a 1 in 43 Chance an Asteroid 2024 YR4 Could Hit Earth in 2032—Should We Worry?
2025-02-13
Sodium Channel Targeting: What the Latest FDA Non-Opioid Approval Reveals About the Next Big Thing in Pain Relief
2025-02-12
Novartis Reclaims Abelacimab in $925M Deal to Boost Cardiovascular Portfolio
2025-02-12
GLP-1 Weight Loss Drugs Might Cause Blindness
2025-02-11
South Korea’s Olix Strikes $660M Deal with Eli Lilly for Phase 1 MASH candidate
2025-02-11
22 USA States Sue Trump Administration for Slashing Critical Medical Research Funding
2025-02-11
EVENT
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-04
MIXiii Health-Tech.IL
Jerusalem, Israel
2025-03-05
Medical Japan
Osaka, Japan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-21
World Vaccine Congress Washington 2025
Washington, U.S.A
Scroll to Top